World Market For Cancer Therapeutics And Biotherapeutics Reports Now Available On Reportsandreports
Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with cancer and nearly 7 million people die. The most common cancers affecting the world include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder.
This Kalorama Information report – The World Market for Cancer Therapeutics and Biotherapeutics – focuses on several segments for cancer treatment. The report covers both currently marketed and late stage development cancer products. Revenues for each current market segment were generated using dollar and unit sales for each product.
The following approaches to cancer therapeutics are covered in the report:
1. Biotherapeutics
Monoclonal Antibodies
Interleukins/ Interferons
Kinases and Other Treatments
2. Chemotherapy
Alkylating Agents
Antimetabolites
Cytotoxic Agents
Plant Derivatives
3. Hormone Therapy
Corticosteroids
Hormone Antagonists/ Antagonists
Aromatase Inhibitors
SERMS
The report includes market share by type of cancer and market share by company for each of the three major segments. It also includes statistical information for cancers by type worldwide, with special emphasis on the U.S. market. Specifically, cancers where there are current products available or are in development and/or have significant incidence/mortality rates are profiled. The market segments provide an overview, description of products on the market, list of products in late-stage development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.
A Primary Research Effort
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives. All market data pertains to the world market at the manufacturers’ level.
Coverage of the Most Recent Product and Trends
The base year for data was 2008. Historical data was provided for the years 2004 through 2007, with forecast data provided for 2009 through 2013. Compound annual growth rates (CAGRs) are provided for the 2004-2008, 2009-2013 and 2004-2013 periods for each industry segment covered. Competitive analysis is provided for the year 2008. The forecasted market analysis for 2009-2013 was based on probability of approval and sales of products in late stage development, product marketing, and demographic trends. Some of the trends that affected this market include the following:
Insurance and Reimbursement
Drug Costs
Personalized Medicine
Alliances, Acquisitions and Licensing Agreements
Alcohol’s Affect on Cancer Incidence
Healthy Lifestyles Continue to Show Promise for Cancer Prevention
Marketing and Distribution Trends
Geographical Trends
Elderly Clinical Trial Involvement
Late-Stage Drug Development Trends
ReportsandReports comprising of an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. ReportsandReports announce to have World Market for Cancer Therapeutics and Biotherapeutics Market Research Report in its store. Browse all our Market Research Reports details at ReportsandReports.com
Article Source
Share this:
Read also:
- Canadian Pharmacy Finds Genes Irrelevant In Breast Cancer Risk
- Women Against Prostate Cancer's Betty Gallo To Testify At House Prostate Cancer Hearing
- Pemetrexed (lung cancer treatment) used in treatmenting for maligant pleural mesothelioma
- Mesothelioma Facts-A brief overview
- The Major Symptoms Of Stomach Cancer
- Bone Cancer Life Expectancy